These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6170209)

  • 21. Thyrotropin-releasing factor: distribution in neural and gastrointestinal tissues.
    Leppäluoto J; Koivusalo F; Kraama R
    Acta Physiol Scand; 1978 Oct; 104(2):175-9. PubMed ID: 102111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substance P in human tears.
    Yamada M; Ogata M; Kawai M; Mashima Y; Nishida T
    Cornea; 2003 Oct; 22(7 Suppl):S48-54. PubMed ID: 14703707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Substance P: localization, concentration and release in cerebral arteries, choroid plexus and dura mater.
    Edvinsson L; Rosendal-Helgesen S; Uddman R
    Cell Tissue Res; 1983; 234(1):1-7. PubMed ID: 6196116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The distribution of substance P-containing nerves to the rat small intestine.
    Amira S; Morrison JF; Rayfield KM
    Exp Physiol; 1990 Jan; 75(1):119-21. PubMed ID: 1690013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization and autoradiographic localization of multiple tachykinin binding sites in gastrointestinal tract and bladder.
    Burcher E; Buck SH; Lovenberg W; O'Donohue TL
    J Pharmacol Exp Ther; 1986 Mar; 236(3):819-31. PubMed ID: 2419545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substance P, acetylcholinesterase, and beta-endorphin levels in the plasma and pericardial fluid of patients with and without angina pectoris.
    Kambam JR; Merrill W; Parris W; Alhaddad R; Naukam R; Stewart J; Bender H; Sastry BV
    J Lab Clin Med; 1990 Nov; 116(5):707-10. PubMed ID: 1700048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increases of substance P-like immunoreactivity within striatal-nigral structures after subacute methamphetamine treatment.
    Ritter JK; Schmidt CJ; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1984 May; 229(2):487-92. PubMed ID: 6201607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetic neuropathy in the rat: 1. Alcar augments the reduced levels and axoplasmic transport of substance P.
    Di Giulio AM; Lesma E; Gorio A
    J Neurosci Res; 1995 Feb; 40(3):414-9. PubMed ID: 7538169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The radioimmunoassay and physiology of somatostatin in the pancreas and gastrointestinal tract.
    McIntosh C; Arnold R
    Z Gastroenterol; 1978 May; 16(5):330-40. PubMed ID: 349906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is substance P the neurotransmitter in the vestibular end organs?
    Ylikoski J; Päivärinta H; Eränkö L; Mrena I; Lehtosalo J
    Acta Otolaryngol; 1984; 97(5-6):523-8. PubMed ID: 6205537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Motilin-, substance P- and somatostatin-like immunoreactivities in extracts from dog, tupaia and monkey brain and GI tract.
    Yanaihara C; Sato H; Yanaihara N; Naruse S; Forssmann WG; Helmstaedter V; Fujita T; Yamaguchi K; Abe K
    Adv Exp Med Biol; 1978; 106():269-83. PubMed ID: 102123
    [No Abstract]   [Full Text] [Related]  

  • 32. Primary afferent origin of substance P-containing axons in the superficial dorsal horn of the rat spinal cord: depletion, regeneration and replenishment of presumed nociceptive central terminals.
    Knyihár-Csillik E; Török A; Csillik B
    J Comp Neurol; 1990 Jul; 297(4):594-612. PubMed ID: 2384613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Release of substance P-like immunoreactivity into the antral lumen of cats.
    Uvnäs-Wallensten K
    Acta Physiol Scand; 1978 Dec; 104(4):464-8. PubMed ID: 726938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substance P in human cerebrospinal fluid: reductions in peripheral neuropathy and autonomic dysfunction.
    Nutt JG; Mrox EA; Leeman SE; Williams AC; Engel WK; Chase TN
    Neurology; 1980 Dec; 30(12):1280-5. PubMed ID: 6161319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gastrointestinal somatostatin: extraction and radioimmunoassay in different species.
    McIntosh C; Arnold R; Bothe E; Becker H; Köbberling J; Creutzfeldt W
    Gut; 1978 Jul; 19(7):655-63. PubMed ID: 680597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of substance P and distribution of substance P-like immunoreactivity in nerves supplying the stomach of the cod, Gadus morhua.
    Jensen J; Karila P; Jönsson AC; Aldman G; Holmgren S
    Fish Physiol Biochem; 1993 Oct; 12(3):237-47. PubMed ID: 24202781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Localization of substance P-like immunoreactivity in cell bodies of the feline dorsal vagal nucleus.
    Maley B; Elde R
    Neurosci Lett; 1981 Dec; 27(2):187-91. PubMed ID: 6172754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parasympathetic neurons of salivary gland ganglia in the fetal and postnatal rat are substance P-like immunoreactive.
    Ayer-Le Lievre C; Seiger A
    Neurosci Lett; 1984 Oct; 51(2):287-92. PubMed ID: 6083514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substance P mechanism in cluster headache: evaluation in plasma and cerebrospinal fluid.
    Sicuteri F; Fanciullacci M; Geppetti P; Renzi D; Caleri D; Spillantini MG
    Cephalalgia; 1985 Sep; 5(3):143-9. PubMed ID: 2412704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Objective evaluation of pain in various spinal diseases: neuropeptide immunoreactivity in the cerebrospinal fluid.
    Imasato H; Nagata K; Hashimoto S; Komori H; Inoue A
    Spinal Cord; 1997 Nov; 35(11):757-62. PubMed ID: 9392047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.